Transgene Biotek reports consolidated net loss of Rs 0.12 crore in the December 2023 quarter
Sales reported at Rs 0.05 crore
Net Loss of Transgene Biotek reported to Rs 0.12 crore in the quarter ended December 2023 as against net loss of Rs 1.38 crore during the previous quarter ended December 2022. Sales reported to Rs 0.05 crore in the quarter ended December 2023. There were no Sales reported during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales0.050 0 OPM %-200.000 -PBDT-0.10-0.14 29 PBT-0.12-1.38 91 NP-0.12-1.38 91Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content